Matthew Meyerson was awarded a prestigious Outstanding Investigator Award (R35 grant) from the National Cancer Institute, effective August 2015 through June 2022. He is one of about 40 scientists nationwide to receive this 7-year research grant, in recognition of his groundbreaking contributions to lung cancer research and of the potential of his research program to continue to engineer genomics-driven breakthroughs in lung cancer biology.
Alice Berger, Research Fellow, was awarded a highly competitive K99/R00 "Pathway to Independence" Award from the National Cancer Institute. The K99/R00 award is given to outstanding fellows with less than 5 years of postdoctoral research training, to encourage their transition to independent academic positions.
Alice's application, on illuminating the role of a recently identified oncogene in lung adenocarcinoma, the small GTPase protein, RIT1, received a score of "10", the highest possible score....congratulations, Alice!!